A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer
2011 ◽
Vol 47
(14)
◽
pp. 2091-2098
◽
2004 ◽
Vol 27
(5)
◽
pp. 441-446
◽
2005 ◽
Vol 23
(16_suppl)
◽
pp. 753-753
◽
2002 ◽
Vol 3
(3)
◽
pp. 183-184
◽
2006 ◽
Vol 29
(3)
◽
pp. 267-275
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 704-704
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 704-704
2006 ◽
Vol 17
(5)
◽
pp. 587-595
◽
2009 ◽
Vol 32
(1-2)
◽
pp. 18-24
◽